News and Views
Nature Cell Biology 10, 125 - 126 (2008)
doi:10.1038/ncb0208-125
ERK and MDM2 prey on FOXO3a
Wensheng Yang1, Nathan G. Dolloff1 & Wafik S. El-Deiry1
-
Wensheng Yang, Nathan G. Dolloff and Wafik S. El-Deiry are in the Laboratory of Molecular Oncology and Cell Cycle Regulation, Departments of Medicine (Hematology/Oncology), Pharmacology, and Genetics, The Abramson Comprehensive Cancer Center, and the Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
e-mail: wafik@mail.med.upenn.edu
Abstract
Constitutively active ERK signalling stimulates cell proliferation, thereby contributing to tumorigenesis. We now learn that ERK activity induces phosphorylation and MDM2-mediated degradation of the tumour-suppressing transcription factor FOXO3a, thus gaining new information on valuable targets for human cancer therapeutic intervention.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradationNature Cell Biology Article (01 Feb 2008)
